Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Emami Multisource Edible Oil (MSEO1)
as cooking oil: dose- 30 ml per day
frequency route of administration - edible cooking oil, to be taken internally
duration of intervention - 28 day
Sponsors
Med Pharma CRO
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female subjects in the age group of 18 years and above. 2. Participants suffering under any one or more of the signs and symptoms like hypertension, dyslipidaemia. 3. Participants willing to give written informed consent. 4. Participants are fit and no need any hospital administration. 5. Willing to cook with the supplied oil and ability to adhere to dosing and visit schedules and meet study requirements. 6. Agree to following instruction of doââ?¬•s and donââ?¬•ts in regular daily lifestyle. 7. Study participants willing to perform all study related procedures allowing the physical and other invasive or non-invasive tests and willing to document symptoms and medication.
Exclusion criteria
Exclusion criteria: 1. Study participants unlikely to comply with the protocol or unable to understand the nature, scope and possible consequences of the study. 2. Inability to carry out testing for the study. 3. Chronic & acute disorders requiring hospital admission. 4. Known HIV-positive, Hepatitis B or C status.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Improvement of Cholesterol 2.Improvement of Blood Pressure 3.Maintaining Cardiovascular Health 4.Improvement of GI issues BMI, BP, CBC, Lipid profile, hsCRP, CPK, Vitamin KTimepoint: BMI, BP, CBC, Lipid profile, hsCRP, CPK, Vitamin K Baseline compared after 28 days then crosover (washout phase 7 days) and again compared after 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| No serious adverse eventsTimepoint: 28 days each group | — |
Countries
India
Contacts
Public ContactDR PARIKSHIT DEBNATH
MED PHARMA CRO
Outcome results
None listed